Monday, 08 June 2009 - biomedreports Seattle Genetics Reports Data from SGN-35 <a href="http://biomedreports.com/articles/latest-news/1188-seattle-genetics-reports-data-from-sgn-35-every-three-week-dosing-phase-i-trial-in-lymphoma.html" rel="nofollow" target="_blank">http://biomedreports.com/articles/latest-news/1188-seattle-genetics-reports-data-from-sgn-35-every-three-week-dosing-phase-i-trial-in-lymphoma.html</a> Micromet Reports Phase 2 Cancer Data <a href="http://biomedreports.com/articles/latest-news/1189-micromet-reports-phase-2-cancer-data.html" rel="nofollow" target="_blank">http://biomedreports.com/articles/latest-news/1189-micromet-reports-phase-2-cancer-data.html</a> Sinovac Begins the Production of Influenza A (H1N1) Vaccine <a href="http://biomedreports.com/articles/latest-news/1190-sinovac-begins-the-production-of-influenza-a-h1n1-vaccine.html" rel="nofollow" target="_blank">http://biomedreports.com/articles/latest-news/1190-sinovac-begins-the-production-of-influenza-a-h1n1-vaccine.html</a> Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data <a href="http://biomedreports.com/articles/latest-news/1191-sangamo-biosciences-presents-positive-phase-2-zfp-therapeutic-data.html" rel="nofollow" target="_blank">http://biomedreports.com/articles/latest-news/1191-sangamo-biosciences-presents-positive-phase-2-zfp-therapeutic-data.html</a>